Detailed ExplanationNLE · Oncology NursingReal content

NLE Oncology Nursing — Cancer Treatment Modalities and Nursing CareDetailed Explanation

Summary Concepts Notes Revision Deep Dive Slides Flashcards Mistakes Cheat Mnemonics Templates

This is the "office hours" version of Cancer Treatment Modalities and Nursing Care for the NLE 2026. No shortcuts, no hand-waving — just a full unpacking of why Professional Regulation Commission (PRC) — Board of Nursing cares about each concept and how the Oncology Nursing section items tend to play out on exam day. Read this once, then hit the practice questions with real understanding.

Exam context

The Philippine Nurse Licensure Examination (PNLE) is conducted by Professional Regulation Commission (PRC) — Board of Nursing and is scheduled for Bi-annual. The Oncology Nursing subtest is marked as "Core" in the official pattern, and Cancer Treatment Modalities and Nursing Care appears in position 2nd of 3 in the NLE Oncology Nursing review rotation. Passing mark: 75% weighted average with no sub-test below 60%. Recent NLE 2026 papers have drawn roughly 50 questions from this subject.

Cancer Treatment Modalities and Nursing Care - Detailed Explanation

Cancer is one of the leading causes of morbidity and mortality in the Philippines, making Oncology Nursing a critical area of competence for every Filipino nurse. Under Republic Act 9173 (Philippine Nursing Act of 2002), nurses are expected to provide safe, evidence-based, and holistic care to cancer patients across all healthcare settings — from tertiary hospitals like Philippine General Hospital (PGH) and National Kidney and Transplant Institute (NKTI) to community health centers. This chapter covers the major cancer treatment modalities: chemotherapy, radiation therapy, surgery, immunotherapy, and targeted therapy. It also addresses the life-threatening oncologic emergencies that require immediate nursing action. Mastery of this content is essential for the NLE, as questions on oncology nursing appear regularly and require both factual recall and clinical decision-making skills.

Concepts

Chemotherapy: Mechanisms, Cell Cycle, and Classification

Chemotherapy refers to the use of cytotoxic (cell-killing) drugs to destroy cancer cells. Because chemotherapy is a systemic treatment — meaning the drugs travel through the bloodstream — it can reach cancer cells anywhere in the body, including sites of metastasis. This is its major advantage over surgery and radiation, which are local treatments. However, this systemic nature also means that normal fast-dividing healthy cells are damaged, which is the root cause of chemotherapy's side effects. The three normal tissue sites most affected are: (1) the bone marrow (causing myelosuppression), (2) the gastrointestinal mucosa (causing stomatitis, nausea, vomiting, diarrhea), and (3) hair follicles (causing alopecia). Chemotherapy drugs are classified based on how they interact with the cell cycle. Cell-cycle-specific (CCS) drugs work only during a specific phase of cell division. For example, antimetabolites like methotrexate and fluorouracil (5-FU) work during the S phase (DNA synthesis), while plant alkaloids like vincristine work during the M phase (mitosis). Because they only work on actively dividing cells, CCS drugs are most effective when given in divided doses or as continuous infusions. Cell-cycle-nonspecific (CCNS) drugs can act in any phase, including resting (G0) cells. Examples include alkylating agents like cyclophosphamide and antitumor antibiotics like doxorubicin. These are often given as single bolus doses because they do not depend on the cell being in a specific phase. In clinical practice, combination chemotherapy regimens are used to maximize tumor cell kill, reduce drug resistance, and allow lower doses of each drug to minimize toxicity. Each drug in a combination protocol works at a different point in the cell cycle or through a different mechanism.

Examples

This illustrates the rationale for combination chemotherapy — maximum tumor kill with minimum individual drug toxicity. This is a common NLE question scenario.

Scenario

A patient with acute lymphocytic leukemia (ALL) is started on a combination chemotherapy regimen that includes methotrexate, vincristine, and cyclophosphamide. The oncologist explains to the student nurse why three drugs are used.

Solution

Each drug works at a different point in the cell cycle: methotrexate (S phase), vincristine (M phase), and cyclophosphamide (cell-cycle-nonspecific). This combination targets leukemia cells at multiple stages, improving the chance of killing all tumor cells while also allowing lower doses of each individual drug.

This reinforces the relationship between cell-cycle specificity and the mode of administration — a concept that frequently appears in NLE questions.

Scenario

A nurse is preparing to administer fluorouracil (5-FU) as a continuous 24-hour infusion rather than a bolus. A nursing student asks why the route of administration is different from other chemotherapy drugs.

Solution

5-FU is a cell-cycle-specific drug (S phase). It can only kill cancer cells that are actively synthesizing DNA at the moment of drug exposure. A continuous infusion maintains therapeutic drug levels over an extended period, exposing more cycling cells to the drug and maximizing efficacy.

Applications

Recognizing which chemotherapy drugs belong to which cell-cycle category helps nurses anticipate the timing and severity of side effects.
Understanding that systemic chemotherapy is appropriate for metastatic disease, while surgery and radiation are local treatments, guides nursing assessment and patient education.
In the Philippine healthcare setting, nurses working in chemotherapy day units must verify drug protocols, reconstitution, and administration schedules according to the physician's order and institutional policy.

Misconceptions

MISCONCEPTION: Chemotherapy only kills cancer cells. FACT: It kills ALL rapidly dividing cells, both malignant and normal, especially in bone marrow, GI mucosa, and hair follicles.
MISCONCEPTION: Cell-cycle-nonspecific drugs are less effective than specific drugs. FACT: CCNS drugs are often MORE potent because they can kill even resting cancer cells.
MISCONCEPTION: All chemotherapy drugs work the same way. FACT: Each drug has a unique mechanism of action; this is why combination regimens are effective.

Related Concepts

Myelosuppression and the nadir
Extravasation of vesicant chemotherapy
Safe handling of hazardous chemotherapy drugs
Side effects of specific drugs: vincristine (neuropathy/constipation), doxorubicin (cardiotoxicity)

Common Exam Questions

Example

Which of the following chemotherapy agents acts during the M phase of the cell cycle? A. Methotrexate B. Fluorouracil C. Vincristine D. Cyclophosphamide. Answer: C. Vincristine is a plant alkaloid (vinca alkaloid) that works in the M phase by inhibiting mitotic spindle formation.

Approach

Identify whether the drug is cell-cycle-specific or nonspecific, then determine which phase it acts on.

Question Type

Drug Classification

Example

The rationale for using combination chemotherapy is to: A. Reduce the number of treatment sessions B. Target cancer cells at different phases of the cell cycle C. Eliminate the need for radiation therapy D. Prevent the need for surgical resection. Answer: B.

Approach

Focus on the benefit of targeting multiple cell cycle phases and reducing resistance.

Question Type

Rationale for Combination Therapy

Key Points To Remember

Chemotherapy is SYSTEMIC — it travels through the bloodstream and reaches cancer throughout the body.
Fast-dividing normal cells most affected: BONE MARROW, GI MUCOSA, and HAIR FOLLICLES.
Cell-cycle-specific (CCS) drugs act in a specific phase (e.g., methotrexate and 5-FU in S phase; vincristine in M phase).
Cell-cycle-nonspecific (CCNS) drugs act in ANY phase, including resting cells (e.g., cyclophosphamide, doxorubicin).
CCS drugs are given in divided or continuous doses; CCNS drugs are often given as a single bolus.
Combination regimens are used to maximize cell kill and reduce resistance.

Myelosuppression, the Nadir, and Neutropenic Precautions

Myelosuppression — suppression of bone marrow function — is the most serious, dose-limiting toxicity of chemotherapy. The bone marrow produces all three blood cell lines: white blood cells (especially neutrophils), platelets, and red blood cells. When chemotherapy damages the bone marrow, all three lines fall. Neutropenia (low neutrophils) is the most dangerous consequence because neutrophils are the body's first line of defense against bacterial and fungal infections. A neutropenic patient cannot mount a normal immune response, so even minor infections can become life-threatening and may present without the usual signs of infection (no pus, minimal redness, no fever — until the infection is overwhelming). Thrombocytopenia (low platelets) increases the risk of bleeding, from minor bruising to life-threatening internal hemorrhage. Anemia (low red blood cells) causes fatigue, pallor, and dyspnea. The NADIR is the point of lowest blood counts after a chemotherapy dose. It typically occurs 7 to 14 days after administration. This is the window when the patient is most vulnerable and requires the closest monitoring. After the nadir, counts gradually recover as the bone marrow regenerates. The Absolute Neutrophil Count (ANC) is the key lab value used to guide neutropenic precautions: ANC below 1,000/mm³ = neutropenia (precautions begin); ANC below 500/mm³ = severe neutropenia (strict precautions mandatory — this is a medical emergency if fever develops). Neutropenic precautions include: placing the patient in a private room with positive-pressure ventilation if available; strict and meticulous hand hygiene for all staff and visitors; restricting visitors who are ill; avoiding fresh flowers, plants, or standing water (sources of Pseudomonas and other organisms); providing a low-bacteria (low-microbial) diet — no raw fruits, vegetables, or undercooked meats; avoiding invasive procedures (rectal temperatures, enemas, suppositories, IM injections) when possible; and monitoring temperature every 4 hours. Granulocyte colony-stimulating factor (G-CSF; filgrastim/Neupogen) may be prescribed to stimulate neutrophil production and shorten the duration of neutropenia.

Examples

Day 10 places the patient within the nadir period (7–14 days). An ANC of 480 (<500) with a fever of 38.2°C meets the criteria for febrile neutropenia. This scenario tests nursing prioritization and the one-hour antibiotic rule — a classic NLE question.

Scenario

A patient receiving CHOP chemotherapy for Non-Hodgkin's Lymphoma is on day 10 post-treatment. The nurse checks the morning CBC: WBC 1.2, ANC 480/mm³, platelets 75,000. The patient has no complaints but the temperature is 38.2°C.

Solution

This is febrile neutropenia — an oncologic emergency. The nurse should immediately: (1) obtain blood cultures (at least two sets from different sites, including any central lines), urine culture, and chest X-ray; (2) notify the physician immediately; (3) prepare to administer broad-spectrum IV antibiotics within one hour of culture collection. Do not delay antibiotics while waiting for culture results.

This is a patient education question using a Filipino cultural context (ensalada is a popular Filipino dish). It tests knowledge of the low-bacteria diet restriction.

Scenario

A nurse is providing discharge teaching to a patient going home after chemotherapy. The patient asks, 'Can I eat fresh papaya and mango salad (ensalada) while I am on chemotherapy?'

Solution

The nurse should advise the patient to avoid raw fruits and vegetables during the nadir period (approximately 7–14 days after each chemotherapy cycle). Fresh papaya and mango salad should be avoided because raw produce may harbor organisms that the neutropenic patient cannot fight. Cooked fruits and vegetables are safer.

Applications

Nursing diagnosis: Risk for Infection related to neutropenia secondary to chemotherapy (NANDA priority in oncology).
Using Maslow's hierarchy: physiological safety (infection prevention) is the highest priority nursing concern for the neutropenic patient.
In Philippine public hospitals, where single rooms may not always be available, the nurse must advocate for the patient's placement and apply strict standard precautions.

Misconceptions

MISCONCEPTION: A neutropenic patient with no fever is not at risk. FACT: Neutropenic patients may not show typical signs of infection (no pus, no redness) — any symptom warrants immediate assessment.
MISCONCEPTION: Antipyretics should be given immediately when a neutropenic patient has a fever. FACT: Cultures must be collected BEFORE giving antipyretics (unless ordered otherwise) so the source of infection can be identified.
MISCONCEPTION: Raw vegetables are safe as long as they are washed. FACT: Even thoroughly washed raw produce can harbor organisms dangerous to severely neutropenic patients — cooking is required.

Related Concepts

Febrile neutropenia as an oncologic emergency
Granulocyte colony-stimulating factors (filgrastim)
Bleeding precautions for thrombocytopenia
Anemia management and fatigue in cancer patients

Common Exam Questions

Example

A cancer patient with an ANC of 450/mm³ has a temperature of 38.4°C. What is the nurse's PRIORITY action? A. Administer acetaminophen and reassess in one hour. B. Obtain blood and urine cultures, then administer prescribed broad-spectrum antibiotics. C. Place the patient in strict isolation and notify the family. D. Check the patient's blood pressure and oxygen saturation. Answer: B. Culture then antibiotic within one hour.

Approach

When a neutropenic patient develops fever, the priority is CULTURES THEN ANTIBIOTICS WITHIN ONE HOUR — never wait for culture results before starting antibiotics.

Question Type

Priority Action

Example

Which of the following foods is SAFE for a patient who is neutropenic? A. Fresh garden salad B. Sushi C. Well-cooked chicken and rice D. Unwashed grapes. Answer: C.

Approach

Identify which foods and activities are SAFE versus UNSAFE for a neutropenic patient.

Question Type

Patient Teaching

Example

A patient received chemotherapy 10 days ago. The ANC today is 380/mm³. The nurse interprets this as: A. Normal recovery B. The nadir period with severe neutropenia C. A sign that chemotherapy was ineffective D. Early bone marrow recovery. Answer: B.

Approach

Identify the ANC threshold and the timing of the nadir.

Question Type

Lab Interpretation

Key Points To Remember

Myelosuppression is the MOST SERIOUS and DOSE-LIMITING toxicity of chemotherapy.
Nadir occurs approximately 7 to 14 days after chemotherapy administration.
ANC below 1,000/mm³ = neutropenia; ANC below 500/mm³ = SEVERE neutropenia.
FEVER in a neutropenic patient (ANC <500) is a MEDICAL EMERGENCY — cultures and broad-spectrum antibiotics within ONE HOUR.
Low-bacteria diet: no raw fruits, vegetables, or undercooked foods.
Avoid rectal temperatures, enemas, suppositories, and unnecessary IM injections in neutropenic patients.
G-CSF (filgrastim) stimulates neutrophil production and shortens nadir duration.
Do NOT take aspirin/NSAIDs when thrombocytopenic — bleeding risk.

Chemotherapy Side Effects: Nausea, Alopecia, Stomatitis, and Extravasation

Beyond myelosuppression, chemotherapy causes several other significant side effects that nursing care can prevent or minimize. Nausea and vomiting are among the most distressing side effects. The key nursing principle is to give antiemetics PROPHYLACTICALLY — before chemotherapy begins — not after nausea has started. The standard antiemetic regimen includes ondansetron (a 5-HT3 serotonin receptor antagonist), aprepitant (a substance-P/neurokinin-1 receptor antagonist), and dexamethasone (a corticosteroid). Antiemetics should continue for 24–48 hours after chemotherapy. Offer small, frequent, bland meals; monitor hydration; replace electrolytes as needed. Alopecia (hair loss) occurs because hair follicles are fast-dividing cells. It is TEMPORARY — hair will regrow after treatment ends, sometimes with a different texture or color (possibly curlier). This is primarily a body-image concern, not a safety issue. Prepare the patient BEFORE chemotherapy begins; suggest wigs, scarves, bandanas, or caps. Stomatitis/mucositis is painful inflammation and ulceration of the oral mucosa. It begins 5–7 days after chemotherapy. Nursing care: perform frequent oral assessment; use a SOFT-BRISTLE TOOTHBRUSH or foam swab; rinse with SALINE or a bland rinse (sodium bicarbonate) every 2–4 hours; avoid alcohol-based mouthwashes (they dry and irritate the mucosa); avoid hot, spicy, acidic foods; use prescribed topical anesthetics (e.g., viscous lidocaine) for pain. Extravasation is the accidental leakage of a vesicant chemotherapy drug from the vein into surrounding tissue. Vesicants (tissue-destroying drugs) include doxorubicin (Adriamycin) and vincristine. Extravasation causes severe pain, blistering, and tissue necrosis, which can require surgical debridement and skin grafting. PRIORITY NURSING ACTIONS: (1) STOP the infusion immediately. (2) Do NOT remove the needle/cannula — leave it in place to aspirate residual drug from the tissue. (3) Apply warm or cold compress depending on the drug (doxorubicin = cold; vinca alkaloids = warm). (4) Give the antidote if available (dexrazoxane for anthracyclines). (5) Elevate the extremity. (6) Notify the physician. (7) Document the site, estimated volume extravasated, and appearance. Prevention is key: verify blood return before each dose, infuse vesicants slowly, and preferably use a central venous access device (CVAD) for known vesicants.

Examples

This tests the priority nursing actions for extravasation. Note: Cold compress for doxorubicin (anthracycline); warm compress for vinca alkaloids (vincristine). This distinction appears on NLE exams.

Scenario

A patient is receiving IV doxorubicin (Adriamycin) through a peripheral IV line. The nurse notices the patient complaining of burning and pain at the IV site, and swelling is visible around the insertion site. The IV pump shows no alarms.

Solution

The nurse should immediately: (1) STOP the infusion — do not continue. (2) Clamp the IV tubing. (3) Leave the needle in place and attempt to aspirate residual doxorubicin from the tissue. (4) Apply a COLD compress to the area (cold for anthracyclines like doxorubicin). (5) Elevate the arm. (6) Notify the oncologist immediately. (7) Document thoroughly. (8) Follow the institution's extravasation protocol.

Alopecia is a body-image issue. Using the nursing diagnosis of Disturbed Body Image, the nurse addresses the patient's psychological concern with accurate, reassuring information — a common NLE patient-teaching scenario.

Scenario

A patient about to receive her first cycle of CHOP chemotherapy (containing doxorubicin) is anxious about hair loss. She asks the nurse, 'Will my hair grow back?'

Solution

The nurse should truthfully reassure the patient that alopecia from chemotherapy is temporary. Hair typically begins to regrow within 3–6 months after completing treatment. The texture may be slightly different (often described as softer or curlier) initially. The nurse can suggest wigs, scarves, or caps, and encourage the patient to get a wig fitted before hair loss begins if she wishes.

Applications

NANDA nursing diagnoses applicable: Nausea, Impaired Oral Mucous Membrane Integrity (stomatitis), Disturbed Body Image (alopecia), Risk for Injury (extravasation), Impaired Comfort.
Patient teaching is a core NLE competency — expect questions about what to teach patients regarding chemotherapy side effects.
In Philippine government hospitals, nurses are often the primary educators for patients and families managing chemotherapy side effects at home between cycles.

Misconceptions

MISCONCEPTION: Antiemetics should only be given when the patient is already nauseated. FACT: Antiemetics must be given PROPHYLACTICALLY, before chemotherapy is administered.
MISCONCEPTION: Alopecia is permanent. FACT: Chemotherapy-induced alopecia is TEMPORARY; hair regrows after treatment ends.
MISCONCEPTION: The IV catheter should be removed immediately if extravasation is suspected. FACT: Leave the catheter in place first to aspirate the drug before removing it.
MISCONCEPTION: Alcohol-based mouthwash helps prevent infection in stomatitis. FACT: Alcohol-based mouthwash dries and irritates already compromised oral mucosa — it should be AVOIDED.

Related Concepts

Safe handling of chemotherapy drugs
Myelosuppression and thrombocytopenic bleeding precautions
Body image and psychological support in oncology
Central venous access devices (CVADs) in chemotherapy delivery

Common Exam Questions

Example

A nurse notices swelling and the patient reports burning at the IV site during doxorubicin infusion. What should the nurse do FIRST? A. Remove the IV catheter and apply a warm compress. B. Slow the infusion rate and reassess in 15 minutes. C. Stop the infusion and leave the catheter in place to aspirate. D. Notify the physician before taking any action. Answer: C.

Approach

Always STOP the infusion first, then leave the needle in place. These two steps are the most commonly tested.

Question Type

Priority Action (Extravasation)

Example

Which oral hygiene instruction is CORRECT for a patient with chemotherapy-induced stomatitis? A. Use Listerine mouthwash three times a day. B. Rinse with saline every 2–4 hours and use a soft-bristle toothbrush. C. Avoid brushing teeth to prevent bleeding. D. Apply toothpaste directly to ulcers for pain relief. Answer: B.

Approach

Know what is APPROPRIATE (saline rinses, soft toothbrush) versus INAPPROPRIATE (alcohol mouthwash, hard brush) for stomatitis.

Question Type

Oral Care Teaching

Key Points To Remember

Give antiemetics PROPHYLACTICALLY before chemotherapy — not after nausea starts. Triple regimen: ondansetron + aprepitant + dexamethasone.
Alopecia is TEMPORARY — reassure the patient; hair will regrow after treatment.
Stomatitis care: soft toothbrush, saline rinses, NO alcohol mouthwash, NO hot/spicy/acidic foods.
Vesicants: DOXORUBICIN and VINCRISTINE — can cause tissue necrosis if they extravasate.
Extravasation emergency: STOP infusion, leave needle in place to aspirate, then follow protocol (compress, antidote, elevate).
Vincristine causes constipation and peripheral neuropathy — unique among common chemo drugs.
Use central venous access devices (CVADs) to reduce extravasation risk with vesicants.

Safe Handling of Chemotherapy Drugs

Chemotherapy drugs are classified as HAZARDOUS drugs because they are mutagenic (cause DNA mutations), teratogenic (cause fetal harm), and carcinogenic (cause cancer in healthy cells with long-term exposure). This means that healthcare workers — including nurses — can be harmed by repeated contact with these drugs through skin absorption, inhalation, or accidental ingestion. Safe handling is not just a best practice; under RA 9173, the Filipino nurse has a legal and ethical duty to protect patients, self, and colleagues from harm. Key safe handling principles: (1) Personal Protective Equipment (PPE): Always wear chemotherapy-rated (ASTM D6978) gloves — double-gloving is recommended. Wear a disposable, fluid-resistant gown. Use eye protection (goggles or face shield) when there is a risk of splashing. (2) Preparation: All chemotherapy drugs must be prepared in a Class II Biological Safety Cabinet (BSC) — a laminar flow hood — to contain aerosols and vapors. Never prepare chemotherapy on an open counter. (3) Pregnant nurses: Pregnant healthcare workers should NOT handle chemotherapy agents or care for patients with internal radioactive implants. This is a critical protective measure for fetal safety. (4) Waste disposal: All used chemotherapy supplies — gloves, gowns, tubing, syringes, empty vials — must be discarded in designated CYTOTOXIC (hazardous) waste containers (typically yellow containers in Philippine hospital color-coding systems). Do NOT discard in regular waste bins. (5) Body fluids: For approximately 48 hours after chemotherapy administration, the patient's body fluids (urine, stool, vomit, sweat) are contaminated with chemotherapy metabolites and are HAZARDOUS. Nurses must wear gloves when handling body fluids and dispose of them appropriately. (6) Spill management: Use a chemotherapy spill kit to contain and clean up any spills. Wear full PPE. Never clean up a chemotherapy spill without proper PPE.

Examples

This scenario tests knowledge of safe handling restrictions for pregnant staff — a frequently tested NLE point.

Scenario

A nursing student is assigned to assist in a chemotherapy unit. She is 3 months pregnant and is asked to help administer cyclophosphamide to a patient.

Solution

The nursing student should decline this assignment and inform the charge nurse immediately. Pregnant healthcare workers must not handle chemotherapy drugs or care for patients receiving them, as these drugs are teratogenic and pose a direct risk to the developing fetus. This is a protective workplace policy under occupational safety guidelines and aligned with the ethical principles in RA 9173.

Waste segregation is part of hospital infection control and safety policy. Under RA 9173, nurses are accountable for maintaining safe practice environments.

Scenario

After administering IV doxorubicin, the nurse needs to dispose of the used IV tubing, empty vial, and gloves. A colleague suggests putting everything in the regular trash bin to save time.

Solution

The nurse should refuse and discard all chemotherapy-contaminated materials in the designated cytotoxic waste container (hazardous waste bin). Disposing of chemotherapy waste in regular trash is a safety violation and exposes other healthcare workers, housekeeping staff, and the environment to hazardous materials.

Applications

Occupational safety for Filipino nurses in chemotherapy units is governed by Department of Health (DOH) guidelines and hospital infection control policies.
Nurses must document chemotherapy administration, including drug name, dose, route, time, site, patient response, and any adverse events.
Orientation of new nurses to chemotherapy units should include mandatory training on safe handling, PPE use, and spill management.

Misconceptions

MISCONCEPTION: Only pharmacists need to worry about chemotherapy safety; nurses are just administering what is already prepared. FACT: Nurses handle chemotherapy during administration and are equally at risk — PPE is required during all steps of administration.
MISCONCEPTION: Chemotherapy is only hazardous while in the vial; once it enters the patient's bloodstream it is safe to handle. FACT: Patient body fluids contain chemotherapy metabolites for about 48 hours and remain hazardous.

Related Concepts

Chemotherapy waste disposal (cytotoxic waste)
Infection control and standard precautions in oncology
Occupational health and safety under RA 9173
Radiation safety principles (parallel concept)

Common Exam Questions

Example

A nurse is preparing to administer IV cyclophosphamide. Which action by the nurse is MOST appropriate? A. Prepare the drug at the nursing station to save time. B. Wear single gloves and a face mask. C. Prepare the drug in a biological safety cabinet wearing chemotherapy-rated gloves and a gown. D. Ask a colleague to prepare the drug to avoid exposure. Answer: C.

Approach

Identify the correct PPE and preparation environment for chemotherapy handling.

Question Type

Safety Protocol

Example

Which staff member should be reassigned away from chemotherapy administration? A. A nurse with diabetes B. A nurse who is 10 weeks pregnant C. A nurse with hypertension D. A nurse over age 50. Answer: B.

Approach

Identify who should NOT handle chemotherapy — pregnant nurses are always the answer.

Question Type

Safe Practice

Key Points To Remember

Chemotherapy drugs are HAZARDOUS: mutagenic, teratogenic, carcinogenic.
Always wear PPE: chemotherapy-rated gloves (double-glove), gown, and eye protection.
Prepare in a BIOLOGICAL SAFETY CABINET (BSC) — never on an open surface.
PREGNANT NURSES must NOT handle chemotherapy or care for internal radiation patients.
Dispose of ALL chemotherapy waste in CYTOTOXIC (hazardous) waste containers.
Treat patient body fluids as HAZARDOUS for approximately 48 hours post-chemotherapy.
Use a SPILL KIT for any chemotherapy spill — wear full PPE.

Radiation Therapy: Types, Skin Care, and Safety

Radiation therapy uses high-energy ionizing radiation to damage the DNA of cancer cells within a precisely targeted area, preventing them from dividing. Unlike chemotherapy, radiation is a LOCAL treatment — its effects (both therapeutic and adverse) are limited to the area being irradiated. There are two main types: External Beam Radiation (Teletherapy): Radiation is delivered from a machine (linear accelerator) outside the body. The patient lies still on a treatment table, and the beam is aimed at the tumor using skin markings (tattoos or permanent marker). CRITICAL POINT: The patient undergoing external beam radiation is NOT radioactive and poses NO radiation risk to others. Nurses, family members, and visitors are completely safe. Brachytherapy (Internal Radiation): A radioactive source is placed INSIDE or directly next to the tumor. A classic example is a sealed implant (cesium) placed in the vagina for cervical cancer — one of the leading cancers among Filipino women. CRITICAL POINT: While the radioactive source is in place, the PATIENT EMITS RADIATION and IS a source of exposure to others. With UNSEALED sources (e.g., radioactive iodine I-131 for thyroid cancer), body fluids are also radioactive. Radiation-induced skin reactions (RADIODERMATITIS): Redness, dryness, itching, peeling, and in severe cases, moist desquamation (weeping skin). This occurs in the treatment field only. Skin Care Teaching for External Radiation Patients: (1) Do NOT wash off the radiation skin markings — these guide the machine to aim the beam precisely at the tumor. If washed off, the beam cannot be accurately targeted. (2) Wash the treatment area gently with lukewarm water and mild soap; PAT DRY — do not rub. (3) Do NOT apply lotions, creams, powders, perfumes, or deodorants to the treatment field — many contain metals (e.g., aluminum in deodorants) that can scatter the radiation beam, increase skin dose, and worsen reactions. (4) Avoid direct sunlight, extreme heat or cold (no heating pads, no ice packs) on the treatment area. (5) Wear soft, loose-fitting cotton clothing over the site. (6) Do NOT scratch or rub the area.

Examples

This tests the key distinction between external beam radiation (patient is NOT radioactive) and brachytherapy (patient IS radioactive). This misunderstanding causes unnecessary anxiety for Filipino families and is a common patient education topic.

Scenario

A patient receiving external beam radiation to the left breast for breast cancer asks her husband if he can still sleep in the same bed with her, because he is worried about radiation exposure.

Solution

The nurse should reassure both the patient and her husband that external beam radiation does NOT make the patient radioactive. The husband and other family members are completely safe. There is no radiation exposure to others when the patient goes home.

This tests radiation skin care — a high-yield NLE topic. The prohibition on lotions/creams/deodorants is one of the most commonly tested radiation care instructions.

Scenario

A patient receiving radiation to the neck and throat area says she has been using her favorite moisturizing lotion on the radiation field every night to prevent dryness. The nurse reviews this practice.

Solution

The nurse should advise the patient to STOP applying any commercial lotion, cream, or deodorant to the radiation treatment field unless it was specifically prescribed by the radiation oncologist. Commercial products may contain metals or chemicals that interfere with radiation delivery and worsen skin reactions. Only prescribed, radiation-safe skin products should be used.

Applications

Cervical cancer is among the top cancers in Filipino women; brachytherapy (intracavitary) is a standard component of treatment. Filipino nurses must be competent in brachytherapy safety protocols.
NANDA nursing diagnoses: Impaired Skin Integrity (radiodermatitis), Deficient Knowledge (radiation skin care), Anxiety (fear of radiation).
In PRC Board Exams, radiation nursing scenarios often focus on safety education for patients and families, and on brachytherapy nursing protocols.

Misconceptions

MISCONCEPTION: All radiation therapy patients emit radiation and are a danger to others. FACT: Only patients with internal radioactive sources (brachytherapy) emit radiation. External beam patients are NOT radioactive.
MISCONCEPTION: Washing off skin markings before bathing is fine as long as the patient redraws them. FACT: Skin markings must NEVER be washed off — they are precision guides for the radiation beam and cannot be accurately redrawn by the patient.
MISCONCEPTION: Applying lotion prevents radiation skin damage. FACT: Many commercial lotions contain metals that can increase skin dose and worsen reactions. Only radiation-oncologist-prescribed products should be used.

Related Concepts

Radiation safety principles (Time, Distance, Shielding)
Brachytherapy nursing protocols
Radioactive iodine therapy for thyroid cancer
Cervical cancer treatment in the Philippine setting

Common Exam Questions

Example

A patient receiving pelvic radiation asks about skin care. Which instruction is CORRECT? A. Apply baby oil to soothe the treatment area daily. B. Wash the area with lukewarm water and mild soap, then pat dry. C. Remove the skin markings after each treatment session. D. Use ice packs to relieve skin discomfort. Answer: B.

Approach

Know what is CORRECT (gentle washing, soft cotton) versus INCORRECT (lotions, deodorant, removing markings) for radiation skin care.

Question Type

Patient Teaching

Example

Which patient requires radiation safety precautions (time, distance, shielding) for the nursing staff? A. A patient completing external beam radiation to the lung B. A patient with a sealed cesium implant for cervical cancer C. A patient who completed radiation six months ago D. A patient receiving oral chemotherapy. Answer: B.

Approach

Identify which type of radiation therapy makes the patient a radiation source (brachytherapy) and which does not (external beam).

Question Type

Radiation Safety

Key Points To Remember

Radiation therapy is a LOCAL treatment — effects are confined to the treatment field.
External beam (teletherapy) patients are NOT radioactive — safe to be around.
Brachytherapy (internal radiation) patients EMIT RADIATION while the source is in place.
NEVER remove or wash off radiation skin markings (used for beam targeting).
NO lotions, powders, perfumes, or deodorants on the treatment field.
Wash gently with lukewarm water and mild soap; pat dry only.
Radioactive iodine (I-131) = unsealed source; body fluids are radioactive.
Sealed brachytherapy source dislodged: use FORCEPS and LEAD CONTAINER — never bare hands.

Radiation Safety: Time, Distance, and Shielding

When a patient has a radioactive implant (brachytherapy), the nurse must apply the three fundamental principles of radiation protection to minimize their own exposure and that of others. These principles form the foundation of all radiation nursing safety protocols. PRINCIPLE 1 — TIME: The less time spent near a radioactive source, the less radiation exposure received. Nurses should organize care tasks efficiently, planning what needs to be done before entering the room. Cluster care activities so that total time near the patient is minimized. Rotate nursing assignments so that no single nurse accumulates excessive radiation exposure. PRINCIPLE 2 — DISTANCE: Radiation intensity decreases rapidly with distance from the source (following the inverse square law — doubling the distance reduces exposure to one-quarter). Maximize distance from the patient and the implant during care. Stand as far from the implant as care allows. PRINCIPLE 3 — SHIELDING: Use lead-lined barriers and shields to absorb radiation. Lead aprons, lead shields, and lead-lined containers are used for protection. Additional brachytherapy safety protocols: (1) PRIVATE ROOM: The patient must be in a private room. (2) FILM BADGE (DOSIMETER): All nursing staff must wear a radiation dosimeter (TLD badge or film badge) to monitor cumulative radiation exposure. (3) NO PREGNANT STAFF OR CHILDREN: Pregnant nurses, nursing students who are pregnant, and children must NOT enter the room or provide care. (4) LEAD-LINED CONTAINER AND FORCEPS: Keep a lead-lined container and long forceps at the patient's bedside at ALL TIMES in case the implant becomes dislodged. (5) DISLODGED IMPLANT PROTOCOL: If the implant falls out — NEVER touch it with bare hands. Pick it up with LONG FORCEPS and place it in the lead-lined container. Notify the radiation oncologist and radiation safety officer immediately. (6) Limit visitor time and maintain distance. Pregnant visitors and children should not visit. (7) Signage: Post radiation precaution signs on the room door.

Examples

This is a classic brachytherapy emergency scenario. The two non-negotiable nursing actions — FORCEPS and LEAD CONTAINER — are the most commonly tested points.

Scenario

A nurse enters the room of a patient with a cervical brachytherapy implant to deliver a meal tray. She notices a small metallic object on the patient's bed near her thighs. The patient says, 'Something fell out of me.'

Solution

The nurse must NOT touch the implant with bare hands. She should: (1) Calmly instruct the patient not to touch the implant. (2) Put on protective equipment. (3) Use the LONG FORCEPS to pick up the implant and place it in the LEAD-LINED CONTAINER at the bedside. (4) Step out of the room. (5) Immediately notify the radiation oncologist and the radiation safety officer.

This scenario tests both radiation safety and professional responsibility under RA 9173. It often appears in NLE situational/ethical questions.

Scenario

A nursing student assigned to the oncology ward is asked to provide morning care for a patient with an intracavitary radium implant for cervical cancer. The student is 6 weeks pregnant but has not yet disclosed this. She is unsure whether to say something.

Solution

The nursing student must immediately inform the charge nurse or clinical instructor that she is pregnant. Pregnant healthcare workers must NOT be assigned to care for brachytherapy patients — this is a non-negotiable safety restriction. Under RA 9173, the nurse has a duty to protect her patient, herself, and her developing fetus. The student should be reassigned to a different patient.

Applications

Understanding radiation safety is essential for nurses working in oncology units, operating rooms, and any setting where radioactive materials are used.
The inverse square law (doubling distance = one-quarter exposure) explains WHY distance is the most cost-effective radiation protection measure.
Film badges must be processed monthly and results kept in the nurse's occupational health record — any excessive exposure triggers an investigation.

Misconceptions

MISCONCEPTION: Wearing gloves protects the nurse from radiation when handling a dislodged implant. FACT: Gloves provide NO radiation protection — only lead shielding and forceps protect against radiation from an implant.
MISCONCEPTION: External beam radiation patients need the same radiation precautions as brachytherapy patients. FACT: External beam patients are NOT radioactive — no radiation precautions are needed for visitors or staff.
MISCONCEPTION: The implant can be removed by a nurse if it becomes dislodged. FACT: Only a trained radiation oncologist or radiation safety officer should handle an implanted radioactive source — the nurse only stabilizes the situation using forceps and lead container.

Related Concepts

Types of radiation therapy (external beam vs. brachytherapy)
Radiation skin care
Pregnant nurse considerations in oncology
Cervical cancer treatment protocols in the Philippines

Common Exam Questions

Example

A nurse finds a dislodged brachytherapy implant on the patient's bed. What is the CORRECT immediate action? A. Pick up the implant with gloved hands and place it on the bedside table. B. Call for help and wait for the physician to arrive. C. Use long forceps to place the implant in the lead-lined container at the bedside. D. Wrap the implant in gauze and place it in the regular waste bin. Answer: C.

Approach

ALWAYS forceps first, lead container second, then notify. Never bare hands.

Question Type

Priority Action (Dislodged Implant)

Example

Which nurse should the charge nurse avoid assigning to care for a patient with a sealed radioactive cervical implant? A. A nurse who is 45 years old B. A nurse with no prior oncology experience C. A nurse who is 20 weeks pregnant D. A nurse who cared for the patient yesterday. Answer: C.

Approach

Always exclude pregnant nurses and children from brachytherapy patient care.

Question Type

Assignment Safety

Key Points To Remember

THREE PRINCIPLES: Time (minimize), Distance (maximize), Shielding (lead).
Private room for all brachytherapy patients.
Wear a FILM BADGE (dosimeter) at all times in the radiation room.
PREGNANT nurses and children must NOT provide care or visit.
Keep LEAD-LINED CONTAINER and LONG FORCEPS at bedside at all times.
NEVER touch a dislodged implant with bare hands — use FORCEPS, place in lead container.
Rotate staff assignments to limit individual nurse's total radiation exposure.
Post RADIATION PRECAUTION signs on the patient's door.

Immunotherapy, Targeted Therapy, and Surgical Modalities

Beyond traditional chemotherapy and radiation, cancer treatment has expanded to include surgery, targeted therapy, and immunotherapy — newer, often more selective approaches. SURGERY remains the oldest and most direct method of cancer treatment. Its purposes include: (1) DIAGNOSIS — biopsy to confirm cancer type and grade; (2) CURE — surgical removal of a localized tumor (e.g., mastectomy for breast cancer, colectomy for colon cancer); (3) DEBULKING (cytoreductive surgery) — reducing the tumor bulk to improve the effectiveness of chemo or radiation; (4) PALLIATION — relieving cancer-related symptoms such as bowel obstruction, pathologic fractures, or pain (not curative but improves quality of life); (5) PROPHYLAXIS (prevention) — removing high-risk tissue before cancer develops (e.g., prophylactic mastectomy in BRCA1/2 gene mutation carriers); (6) RECONSTRUCTION — restoring form and function after cancer surgery (e.g., breast reconstruction after mastectomy). Nursing care for cancer surgery follows general perioperative principles, with additional attention to nutritional status, immune function, and the psychological impact of cancer surgery. TARGETED THERAPY attacks specific molecular targets (proteins or genes) unique to cancer cells, minimizing damage to normal cells. Key examples: (1) Trastuzumab (Herceptin) — targets HER2-positive breast cancer. Major toxicity: CARDIOTOXICITY (monitor ejection fraction via echocardiogram). (2) Rituximab (Rituxan) — targets CD20 on B-cell lymphomas. Major concern: INFUSION REACTIONS (fever, chills, hypotension — monitor closely during first infusion). (3) Imatinib (Gleevec) — tyrosine kinase inhibitor for chronic myeloid leukemia (CML). IMMUNOTHERAPY enhances the body's own immune system to fight cancer. Key examples: (1) Interferons and Interleukins — stimulate immune cell activity; cause FLU-LIKE SYMPTOMS (fever, chills, myalgia, fatigue). (2) Immune checkpoint inhibitors (e.g., pembrolizumab, nivolumab) — block proteins (PD-1, CTLA-4) that cancer cells use to hide from the immune system. Key toxicity: IMMUNE-RELATED ADVERSE EVENTS (irAEs) — autoimmune inflammation in ANY organ (colitis, pneumonitis, hepatitis, endocrinopathies, rash). Nursing priorities for targeted therapy and immunotherapy: monitor for infusion reactions during the first dose (have emergency equipment, antihistamines, epinephrine ready); educate patients on the specific toxicity profile of their medication; report new symptoms in any organ system that may represent immune-related adverse events.

Examples

Cardiotoxicity is the hallmark adverse effect of trastuzumab. This is a high-frequency NLE topic in targeted therapy.

Scenario

A patient with HER2-positive breast cancer has been on trastuzumab for 6 months. She is scheduled for a routine clinic visit. Which assessment does the oncology nurse prioritize?

Solution

The nurse should prioritize cardiac assessment — specifically monitoring for signs of heart failure (dyspnea, edema, fatigue, decreased exercise tolerance) and reviewing the patient's most recent echocardiogram results. Trastuzumab is associated with cardiotoxicity and a decrease in ejection fraction. Any new cardiac symptoms should be reported to the oncologist immediately.

Immune-related adverse events (irAEs) from checkpoint inhibitors can mimic autoimmune diseases and can affect any organ. Early recognition and corticosteroid therapy are key.

Scenario

A patient with stage IV melanoma is receiving pembrolizumab (a PD-1 checkpoint inhibitor). Three weeks after starting treatment, he presents with diarrhea (8 stools per day), abdominal cramping, and low-grade fever.

Solution

The nurse should assess for immune-related colitis — an immune-related adverse event (irAE) from checkpoint inhibitor therapy. The nurse should immediately report these findings, collect stool specimens, ensure the patient is adequately hydrated, and anticipate the physician ordering systemic corticosteroids (which are the mainstay of irAE management). Pembrolizumab may need to be held.

Applications

Targeted therapy and immunotherapy represent the future of cancer treatment in the Philippines; Filipino nurses must be prepared to monitor for novel toxicities.
NANDA diagnoses: Decreased Cardiac Output (trastuzumab), Diarrhea (checkpoint inhibitor colitis), Risk for Injury (infusion reaction).
Patient education: Teach patients to report ANY new or unusual symptoms — not just the typical chemotherapy side effects — when receiving immunotherapy.

Misconceptions

MISCONCEPTION: Targeted therapy has no side effects because it is 'targeted.' FACT: Targeted drugs have specific but serious toxicities (e.g., cardiotoxicity with trastuzumab) that require close monitoring.
MISCONCEPTION: Immunotherapy is always safer than chemotherapy. FACT: Checkpoint inhibitors can cause severe autoimmune reactions in any organ system, which can be life-threatening.
MISCONCEPTION: Debulking surgery cures cancer. FACT: Debulking reduces tumor mass to improve the effectiveness of other treatments; it does not cure cancer by itself.

Related Concepts

Myelosuppression from chemotherapy
Infusion reaction management
Cardiac monitoring in oncology
Perioperative nursing care

Common Exam Questions

Example

A patient receiving trastuzumab for breast cancer reports increasing shortness of breath and ankle swelling. What should the nurse suspect? A. Pleural effusion from metastasis B. Cardiotoxicity from trastuzumab C. Infusion reaction D. Pulmonary embolism. Answer: B.

Approach

Match the targeted therapy drug to its most important monitoring parameter.

Question Type

Drug-Specific Monitoring

Example

A patient on nivolumab (PD-1 inhibitor) develops new-onset dyspnea and hypoxia. The nurse suspects: A. Pneumonia B. Immune-related pneumonitis C. Heart failure D. Anemia-related dyspnea. Answer: B.

Approach

Know that checkpoint inhibitors cause immune-related adverse events in any organ.

Question Type

Side Effect Recognition

Key Points To Remember

Surgery purposes: Diagnosis, Cure, Debulking, Palliation, Prophylaxis, Reconstruction.
Targeted therapy hits specific cancer molecules — more selective, fewer side effects than traditional chemo.
Trastuzumab (HER2-positive breast cancer) → monitor CARDIAC FUNCTION (cardiotoxicity).
Rituximab (B-cell lymphoma) → monitor for INFUSION REACTIONS.
Immunotherapy (interferons, interleukins) → FLU-LIKE SYMPTOMS.
Checkpoint inhibitors → IMMUNE-RELATED ADVERSE EVENTS in any organ system.
Always have emergency equipment ready for first infusion of targeted therapy or immunotherapy.
Imatinib = tyrosine kinase inhibitor for CML.

Oncologic Emergencies

Oncologic emergencies are life-threatening complications of cancer or its treatment that require immediate recognition and intervention. In the NLE, questions about oncologic emergencies test both knowledge of the specific emergency and the correct nursing priority action. Every Filipino nurse working with cancer patients must memorize these five emergencies. 1. FEBRILE NEUTROPENIA: Fever (≥38.3°C once, or ≥38.0°C sustained for ≥1 hour) in a patient with ANC <500/mm³. It is a medical emergency because the patient may have overwhelming infection with minimal outward signs. PRIORITY: Obtain blood cultures (at least 2 sets), urine culture, and CXR — then START BROAD-SPECTRUM IV ANTIBIOTICS WITHIN ONE HOUR. Do not wait for culture results. 2. TUMOR LYSIS SYNDROME (TLS): Occurs when chemotherapy rapidly destroys a large tumor burden (most common in leukemia and Burkitt's lymphoma), releasing intracellular contents into the blood. CLASSIC METABOLIC ABNORMALITIES: Hyperkalemia + Hyperphosphatemia + Hyperuricemia + Hypocalcemia. Consequences: ACUTE KIDNEY INJURY and FATAL CARDIAC ARRHYTHMIAS. MANAGEMENT: Aggressive IV hydration; allopurinol or rasburicase to lower uric acid; correct electrolytes; monitor cardiac rhythm and renal function. 3. SUPERIOR VENA CAVA (SVC) SYNDROME: Compression or obstruction of the SVC by tumor (most commonly lung cancer or lymphoma), blocking venous return from the head and upper body. SIGNS: Facial edema, neck swelling, arm edema, distended neck and chest veins, dyspnea, headache, and 'fullness in the head.' PRIORITY NURSING ACTION: Elevate the HEAD OF BED. Medical management: oxygen, diuretics, and urgent radiation or chemotherapy to shrink the tumor. 4. SPINAL CORD COMPRESSION: Tumor metastasis to the vertebrae compresses the spinal cord. EARLIEST SYMPTOM: BACK PAIN — report ANY new or worsening back pain in a cancer patient immediately. Progression: motor weakness, sensory changes, then bowel and bladder dysfunction. Permanent paralysis results if not treated promptly. MANAGEMENT: High-dose corticosteroids (dexamethasone) to reduce edema + radiation or surgery. 5. HYPERCALCEMIA: Caused by bone metastasis or tumor-produced parathyroid hormone-related protein (PTHrP) releasing calcium from bones. SIGNS (remember 'groans, bones, moans, and stones'): fatigue, muscle weakness, confusion, lethargy, nausea, constipation, polyuria, polydipsia. Severe: cardiac arrhythmias and coma. MANAGEMENT: Aggressive IV NORMAL SALINE hydration (first line) + bisphosphonates (zoledronic acid or pamidronate) to inhibit bone resorption + loop diuretics after rehydration.

Examples

The classic presentation of hypercalcemia in a cancer patient is tested frequently on the NLE. The priority intervention is IV hydration with normal saline — not diuretics first.

Scenario

A patient with multiple myeloma is admitted with confusion, profound weakness, severe constipation for 5 days, increased thirst and urination, and a serum calcium of 14.2 mg/dL (normal: 8.5–10.5 mg/dL).

Solution

This is hypercalcemia — a common oncologic emergency in patients with bone metastasis (multiple myeloma extensively involves bones). Priority nursing actions: (1) Establish large-bore IV access. (2) Initiate aggressive IV normal saline hydration as prescribed. (3) Monitor cardiac rhythm (hypercalcemia causes arrhythmias). (4) Monitor fluid intake and output. (5) Administer bisphosphonates (e.g., zoledronic acid) as ordered. (6) Implement fall and confusion precautions. (7) Notify the physician immediately.

TLS presents with the specific metabolic quartet: Hyperkalemia + Hyperphosphatemia + Hyperuricemia + Hypocalcemia. This is the most commonly tested oncologic emergency related to cancer treatment in the NLE.

Scenario

A patient with chronic myeloid leukemia (CML) has just started induction chemotherapy. Within 24 hours, the nurse notes the following lab results: serum potassium 6.8 mEq/L (high), phosphorus 7.2 mg/dL (high), uric acid 14 mg/dL (high), calcium 6.8 mg/dL (low). The patient is on continuous cardiac monitoring.

Solution

This is Tumor Lysis Syndrome (TLS) — a medical emergency. The nurse should: (1) Notify the physician immediately. (2) Ensure aggressive IV hydration is running as ordered. (3) Monitor continuous cardiac rhythm for dysrhythmias (hyperkalemia and hypocalcemia both cause lethal arrhythmias). (4) Administer allopurinol or rasburicase as ordered to reduce uric acid. (5) Prepare for possible dialysis if renal function deteriorates. (6) Monitor urine output every hour. (7) Prepare calcium gluconate at bedside for symptomatic hypocalcemia.

SVC syndrome is recognized by the classic 'head and upper body' venous congestion pattern. The priority action — elevating the head of the bed — is the most commonly tested nursing intervention for SVC syndrome.

Scenario

A patient with stage IIIB non-small cell lung cancer presents to the emergency department with marked puffiness of the face, especially around the eyes, swelling of both arms, engorged neck veins, and increasing shortness of breath. The patient says his collar 'feels too tight' when he wakes up in the morning.

Solution

This is Superior Vena Cava (SVC) Syndrome — obstruction of the SVC by the lung tumor. Priority nursing action: ELEVATE THE HEAD OF BED to at least 30–45 degrees to reduce venous pressure in the upper body. Administer supplemental oxygen. Notify the physician. Anticipate orders for diuretics and urgent radiation or chemotherapy to reduce the tumor compressing the SVC. Avoid venipuncture and IV insertion in the upper extremities (they will have poor venous return).

Applications

Rapid recognition and response to oncologic emergencies is a core NLE competency tested in priority-setting questions.
In Philippine emergency departments and oncology wards, the nurse must be the first to recognize these emergencies and initiate life-saving measures.
Maslow's prioritization: All oncologic emergencies represent PHYSIOLOGICAL needs at the SURVIVAL level — always the top priority.
NANDA diagnoses: Decreased Cardiac Output (TLS arrhythmias), Impaired Gas Exchange (SVC syndrome), Risk for Paralysis (spinal cord compression), Deficient Fluid Volume (hypercalcemia with polyuria).

Misconceptions

MISCONCEPTION: Antipyretics should be given first when a neutropenic patient has fever. FACT: CULTURES FIRST, then antibiotics within one hour — fever masking with antipyretics before culture collection is inappropriate.
MISCONCEPTION: IV normal saline is given slowly for hypercalcemia to prevent fluid overload. FACT: The treatment requires AGGRESSIVE IV hydration — large volumes of normal saline are needed to flush calcium through the kidneys.
MISCONCEPTION: Back pain in a cancer patient is always from the tumor itself or musculoskeletal causes. FACT: New or worsening back pain in a cancer patient must be urgently evaluated for spinal cord compression — a delay can result in permanent paralysis.
MISCONCEPTION: Diuretics are the first treatment for hypercalcemia. FACT: IV hydration (normal saline) comes FIRST; diuretics (furosemide) are used AFTER adequate hydration to enhance calcium excretion.
MISCONCEPTION: Tumor lysis syndrome only occurs days after chemotherapy. FACT: TLS can begin within 12–24 hours of starting chemotherapy, especially with highly chemosensitive tumors like Burkitt's lymphoma and ALL.

Related Concepts

Febrile neutropenia and neutropenic precautions
Myelosuppression and ANC monitoring
Electrolyte imbalances and cardiac arrhythmias
Spinal cord injury and neurological nursing care
Palliative care and quality of life in oncology

Common Exam Questions

Example

A patient with lymphoma has facial swelling, distended neck veins, and severe dyspnea. What is the nurse's PRIORITY action? A. Prepare for emergency intubation. B. Elevate the head of the bed. C. Administer IV furosemide. D. Obtain a stat chest X-ray. Answer: B. Elevating the head of the bed is the immediate nursing priority for SVC syndrome.

Approach

Identify the emergency, then identify the FIRST/PRIORITY nursing action for that specific emergency.

Question Type

Priority Nursing Action

Example

A patient 12 hours after starting chemotherapy for Burkitt's lymphoma has K+ 6.5, Phosphorus 7.0, Uric acid 12, Ca2+ 7.0. The nurse recognizes this as: A. Normal post-chemotherapy labs B. Tumor lysis syndrome C. Hypercalcemia D. Hypokalemia. Answer: B.

Approach

Recognize the metabolic quartet of TLS: high K, high Phosphorus, high Uric Acid, low Calcium.

Question Type

Lab Interpretation

Example

A patient with prostate cancer being treated on the oncology ward tells the nurse that he has had worsening lower back pain for the past three days. The nurse's most appropriate action is: A. Reassure the patient that back pain is expected with cancer. B. Give the prescribed analgesic and reassess. C. Report the back pain to the physician immediately and assess for neurological changes. D. Order a heating pad for comfort. Answer: C.

Approach

Back pain in a cancer patient = spinal cord compression until proven otherwise.

Question Type

Early Warning Recognition

Key Points To Remember

FEBRILE NEUTROPENIA: ANC <500 + fever → blood cultures THEN broad-spectrum antibiotics within ONE HOUR.
TUMOR LYSIS SYNDROME: Hyperkalemia + Hyperphosphatemia + Hyperuricemia + Hypocalcemia → hydrate + allopurinol/rasburicase.
SVC SYNDROME: Facial/neck swelling, distended veins → ELEVATE HEAD OF BED + urgent radiation/chemo.
SPINAL CORD COMPRESSION: BACK PAIN is the EARLIEST sign in a cancer patient → dexamethasone + radiation/surgery.
HYPERCALCEMIA: Confusion, weakness, constipation, polyuria → IV NORMAL SALINE first + bisphosphonates.
Tumor lysis syndrome risk: highest in leukemia and Burkitt's lymphoma with bulky disease.
Any new back pain in a known cancer patient = REPORT IMMEDIATELY — do not dismiss as musculoskeletal.
Loop diuretics for hypercalcemia are used AFTER rehydration — never before, to avoid worsening hypovolemia.

Practice Problems

This scenario integrates multiple oncology nursing concepts: nadir timing, febrile neutropenia emergency, myelosuppression management, stomatitis care, and NANDA diagnosis prioritization. The one-hour antibiotic rule is non-negotiable. Notice that while the patient has three problems (neutropenia, thrombocytopenia, anemia), febrile neutropenia is the MOST LIFE-THREATENING and therefore the top priority — demonstrating Maslow's survival-level physiological needs prioritization.

Problem

A 52-year-old woman with stage III breast cancer is receiving her 3rd cycle of AC chemotherapy (doxorubicin + cyclophosphamide). It is day 11 post-chemotherapy. The nurse's morning assessment reveals: T 38.5°C, HR 102, BP 108/70, RR 20, SpO2 96%. CBC shows WBC 1.1, ANC 390/mm³, Platelets 62,000, Hgb 9.2. The patient says she has a sore mouth and feels very tired. Question: (a) What oncologic complication is this patient experiencing? (b) What are the nurse's PRIORITY interventions in order? (c) What two nursing diagnoses are MOST appropriate for this patient?

Solution

(a) FEBRILE NEUTROPENIA — the patient has a fever of 38.5°C and an ANC of 390/mm³ (<500/mm³), meeting the criteria for this oncologic emergency. She is also in her nadir period (day 11, within the 7–14 day window). (b) PRIORITY INTERVENTIONS in order: (1) Notify the physician IMMEDIATELY — this is an emergency. (2) Obtain blood cultures (minimum 2 sets from different sites), urine culture, and throat swab (do NOT wait for results). (3) Administer prescribed broad-spectrum IV antibiotics WITHIN ONE HOUR of culture collection. (4) Monitor vital signs every 1–2 hours. (5) Implement strict neutropenic precautions: private room, meticulous hand hygiene, limit visitors, low-bacteria diet. (6) Assess oral mucosa (patient has sore mouth — assess for stomatitis/mucositis). (7) Implement bleeding precautions for thrombocytopenia (platelets 62,000): soft toothbrush, no NSAIDs, no IM injections, electric razor. (8) Monitor fluid intake and output. (c) PRIORITY NURSING DIAGNOSES: (1) Risk for Infection related to neutropenia (ANC 390) secondary to chemotherapy-induced myelosuppression — HIGHEST PRIORITY based on Maslow's physiological survival needs. (2) Impaired Oral Mucous Membrane Integrity related to chemotherapy-induced stomatitis as evidenced by patient's report of a sore mouth.

This scenario tests radiation safety principles in a realistic clinical context. Three key NLE points are tested: (1) who can and cannot be in the room (children excluded), (2) the never-touch-with-bare-hands rule, and (3) the forceps and lead container protocol for a dislodged implant. The scenario also tests professional communication with the patient's family.

Problem

A patient with cervical cancer has a sealed radioactive cesium implant in place as part of brachytherapy treatment. While the nurse is providing morning care, the patient's husband arrives and says he wants to help with his wife's bath to support her. Their 8-year-old daughter is with him and wants to visit. The husband is also concerned because he noticed the implant 'has moved' and asks the nurse to 'just push it back in.' Question: (a) Who should be allowed to enter the room, and why? (b) How should the nurse respond to the husband's request about the implant? (c) What should the nurse do if she confirms the implant has become dislodged?

Solution

(a) ROOM ENTRY RULES for brachytherapy patient: The husband (adult, non-pregnant) may briefly visit but should LIMIT TIME and maintain DISTANCE from the implant. The 8-year-old daughter should NOT enter the room because children have more sensitive rapidly dividing tissues and are more vulnerable to radiation damage. The husband should NOT participate in direct care (bathing) because this would require prolonged close contact with the radioactive source. (b) The nurse should calmly but firmly explain to the husband that he must NOT attempt to reposition or touch the implant. Touching a dislodged radioactive implant with bare hands is dangerous — it can cause radiation injury to the person handling it. Repositioning an implant requires the radiation oncologist. The nurse should immediately assess whether the implant is truly dislodged. (c) IF IMPLANT IS DISLODGED: (1) Do NOT touch with bare hands — this is the cardinal rule. (2) Instruct the patient and husband NOT to touch the implant. (3) Put on radiation protection and use the LONG FORCEPS at the bedside. (4) Pick up the implant with forceps and place it in the LEAD-LINED CONTAINER at the bedside. (5) Exit the room. (6) IMMEDIATELY notify the radiation oncologist and radiation safety officer. (7) Document the event thoroughly.

This is a comprehensive TLS scenario that tests metabolic interpretation, mechanism understanding, and nursing priority action. The NLE frequently asks candidates to identify TLS from lab values and then select the correct management. Note that the ECG change (peaked T-waves from hyperkalemia) adds clinical urgency — this is a potential fatal arrhythmia and is the MOST IMMEDIATELY life-threatening complication.

Problem

A patient newly diagnosed with Burkitt's lymphoma (a rapidly growing lymphoma) is started on induction chemotherapy. The oncology nurse reviews the following labs obtained 18 hours after the first chemotherapy dose: Potassium 6.9 mEq/L (normal: 3.5–5.0), Phosphorus 7.5 mg/dL (normal: 2.5–4.5), Uric acid 13.2 mg/dL (normal: 3.5–7.2), Calcium 6.5 mg/dL (normal: 8.5–10.5), Creatinine 2.8 mg/dL (normal: 0.6–1.2). The patient is on continuous cardiac monitoring and is now showing peaked T-waves on ECG. Question: (a) What emergency is occurring? (b) What has caused this? (c) List the PRIORITY nursing interventions.

Solution

(a) TUMOR LYSIS SYNDROME (TLS) — confirmed by the classic metabolic quartet: Hyperkalemia (K 6.9), Hyperphosphatemia (P 7.5), Hyperuricemia (Uric acid 13.2), and Hypocalcemia (Ca 6.5). Peaked T-waves on ECG indicate a cardiac manifestation of hyperkalemia — an immediately life-threatening arrhythmia risk. Elevated creatinine indicates acute kidney injury — a complication of TLS. (b) CAUSE: Burkitt's lymphoma is one of the fastest-dividing cancers. Chemotherapy rapidly destroyed a massive number of tumor cells. The intracellular contents — potassium, phosphate, nucleic acids (converted to uric acid), and proteins — were released into the bloodstream simultaneously, overwhelming the kidneys' ability to excrete them. As phosphate rises, it binds calcium, causing hypocalcemia. Uric acid crystals form in renal tubules, causing acute kidney injury. (c) PRIORITY NURSING INTERVENTIONS: (1) NOTIFY PHYSICIAN IMMEDIATELY — this is a critical emergency. (2) Ensure continuous cardiac monitoring — peaked T-waves indicate dangerous hyperkalemia; prepare for possible ventricular arrhythmia. (3) Ensure aggressive IV hydration with normal saline is running at prescribed rate to flush uric acid and electrolytes through the kidneys. (4) Administer allopurinol or rasburicase as prescribed to lower uric acid. (5) Administer calcium gluconate IV as prescribed (for symptomatic hypocalcemia and to protect the heart from hyperkalemia effects). (6) Prepare for possible administration of sodium bicarbonate (alkalinizes urine to increase uric acid solubility). (7) Monitor urine output every hour (target >100 mL/hour). (8) Prepare for possible emergency dialysis if renal failure worsens. (9) Restrict potassium in IV fluids and diet. (10) Continue continuous cardiac monitoring and document rhythm strips.

Extravasation is one of the most commonly tested chemotherapy safety topics on the NLE. The two most critical steps — STOP the infusion and LEAVE THE NEEDLE IN to aspirate — are tested repeatedly. The cold versus warm compress distinction (cold for anthracyclines, warm for vinca alkaloids) also appears frequently. Doxorubicin is an anthracycline; vincristine is a vinca alkaloid — both are classic vesicants.

Problem

A nurse is preparing to administer a vesicant chemotherapy drug (doxorubicin) through a peripheral IV catheter in the right antecubital fossa. Twenty minutes into the infusion, the patient reports a burning sensation at the IV site. The nurse assesses the site and notes: slight swelling, redness around the insertion site, and the pump is alarming for high pressure. Question: (a) What complication is occurring? (b) What are the nurse's immediate priority actions in the CORRECT order? (c) What teaching should have been done before starting a vesicant infusion peripherally?

Solution

(a) EXTRAVASATION — leakage of doxorubicin (a vesicant chemotherapy drug) out of the vein into surrounding tissue. The signs — burning, swelling, redness at the IV site, and high pump pressure (indicating resistance) — confirm that the drug is no longer flowing into the vein properly. (b) PRIORITY ACTIONS IN ORDER: (1) STOP the infusion IMMEDIATELY — clamp the IV tubing. This is the FIRST and most critical action. Do not slow the rate; stop completely. (2) Do NOT remove the IV catheter — leave it in place to aspirate any residual doxorubicin from the tissue using a syringe. (3) Attempt to aspirate as much drug as possible through the existing catheter. (4) After aspiration, remove the catheter. (5) Apply a COLD COMPRESS to the affected area (cold/ice for anthracyclines like doxorubicin — reduces local drug uptake and tissue damage). Do NOT apply heat to anthracycline extravasation. (6) ELEVATE the affected extremity (right arm). (7) Notify the physician IMMEDIATELY. (8) Administer the antidote as prescribed — dexrazoxane (Totect) is the specific antidote for anthracycline extravasation. (9) Document the event thoroughly: time discovered, estimated volume extravasated, site description, photograph if possible, nursing actions taken. (10) Follow institutional extravasation protocol. (c) PRE-INFUSION TEACHING/PREVENTION: Before starting vesicant infusions, the nurse should: confirm blood return from the IV catheter; explain to the patient to report immediately any burning, stinging, or swelling at the IV site; where possible, use a central venous access device (CVAD/port) for vesicant administration; verify line patency with normal saline before starting.

Exam Preparation Tips

MEMORIZE THE NADIR: 7–14 days after chemotherapy is the nadir (lowest blood counts). Any question mentioning a patient 'one to two weeks' after chemo who has a fever should immediately signal febrile neutropenia.
THE ONE-HOUR ANTIBIOTIC RULE: For febrile neutropenia (ANC <500 + fever ≥38°C), cultures come first, then broad-spectrum antibiotics must be started within ONE HOUR. This rule is absolute and non-negotiable in the NLE.
LEARN THE TLS QUARTET: Hyperkalemia + Hyperphosphatemia + Hyperuricemia + Hypocalcemia = Tumor Lysis Syndrome. If you see these four together in a cancer patient who just started chemo, answer TLS every time.
RADIATION PATIENT TYPE DETERMINES SAFETY RULES: External beam = patient NOT radioactive (no special precautions needed for staff/visitors). Brachytherapy = patient IS radioactive (time, distance, shielding required). This distinction appears on almost every NLE exam.
NEVER TOUCH A DISLODGED IMPLANT WITH BARE HANDS: Forceps to pick it up + lead-lined container to store it. This two-step answer will get you full marks on any brachytherapy emergency question.
SKIN MARKINGS ARE SACRED: Do NOT wash off radiation skin markings. Do NOT apply any lotion, powder, deodorant, or perfume to the radiation field. These are among the most commonly tested radiation skin care instructions.
VESICANT RULE: STOP the infusion, LEAVE THE NEEDLE IN, aspirate residual drug. Cold compress for anthracyclines (doxorubicin); warm compress for vinca alkaloids (vincristine). Vesicant = potential tissue necrosis.
PREGNANT NURSES: Cannot handle chemotherapy. Cannot care for brachytherapy patients. Cannot care for patients receiving radioactive iodine. These exclusions are absolute and regularly tested.
SVC SYNDROME PRIORITY ACTION: Elevate the head of the bed. Recognize it by the 'head-and-upper-body congestion' picture: facial/neck swelling, arm edema, distended neck veins, dyspnea.
SPINAL CORD COMPRESSION: ANY new or worsening back pain in a cancer patient = REPORT IMMEDIATELY. Do not dismiss it. Back pain → weakness → bowel/bladder changes = emergency. Treatment = dexamethasone + radiation.
HYPERCALCEMIA FIRST TREATMENT: Aggressive IV NORMAL SALINE hydration comes FIRST — not diuretics. Bisphosphonates (zoledronic acid) follow. Diuretics only after rehydration.
ANTIEMETICS ARE PROPHYLACTIC: Give BEFORE chemotherapy, not after nausea starts. Triple regimen: ondansetron + aprepitant + dexamethasone.
CREATE A COMPARISON TABLE: Make a personal table of the five oncologic emergencies (Febrile Neutropenia, TLS, SVC Syndrome, Spinal Cord Compression, Hypercalcemia) with columns for: Cause, Key Signs/Symptoms, Priority Nursing Action, Medical Management.
USE MNEMONICS: For TLS metabolic changes — 'HyPER hyPER hyPER hyPO' (hyperK, hyperPhos, hyperUricemia, hypoCa). For hypercalcemia symptoms — 'Groans (GI: constipation, nausea), Bones (bone pain), Moans (psyche: confusion, lethargy), Stones (renal: polyuria, kidney stones)'.
PRACTICE PRIORITIZATION: NLE questions on oncology frequently ask 'which assessment finding requires IMMEDIATE reporting?' Train yourself to identify the most life-threatening finding: fever in neutropenic patient > bleeding > pain > fatigue.
KNOW RA 9173 CONTEXT: Under the Philippine Nursing Act of 2002, nurses have the legal and ethical duty to maintain competence, protect patients from harm, and maintain safe practice environments — including safe chemotherapy handling and radiation safety.

Loading diagram…

In summary

Cancer Treatment Modalities and Nursing Care is one of the most clinically significant and NLE-relevant topics in Oncology Nursing. Filipino nurses must be equipped with a thorough understanding of how each treatment modality works, what complications it causes, and how to respond — both to protect their patients and to fulfill their professional responsibilities under Republic Act 9173. The key themes to carry forward are: chemotherapy is systemic and its most dangerous toxicity is myelosuppression, with the nadir occurring 7–14 days after administration; febrile neutropenia is a time-critical emergency requiring cultures and antibiotics within one hour; extravasation of vesicant drugs requires immediate cessation of the infusion with the needle left in place for aspiration; radiation therapy is local, and external beam patients are not radioactive while brachytherapy patients are; radiation skin markings must never be removed and no lotions or deodorants should be applied to the treatment field; brachytherapy safety demands time, distance, and shielding, and a dislodged implant must never be touched with bare hands — only forceps and a lead container; and the five oncologic emergencies — febrile neutropenia, tumor lysis syndrome, SVC syndrome, spinal cord compression, and hypercalcemia — each have specific, immediately actionable nursing responses that can be the difference between life, disability, and death. In the Philippine healthcare context, where nurses often serve as the primary point of clinical monitoring and patient education — especially in resource-limited settings — mastery of these concepts translates directly to better patient outcomes and safer nursing practice. Review the visual aids, practice the priority-action scenarios, and internalize the NLE exam preparation tips provided in this chapter. You are prepared to protect your patients and pass your boards.

Previous chapter

Cancer Pathophysiology, Prevention and Detection

Next chapter

Palliative, Hospice and End-of-Life Care

Ready to practise for the NLE 2026?

Super Tutor's AI review plan adapts to your weak areas and builds a weekly practice schedule around your target NLE exam date.

Start free See the full NLE guide NLE preparation guide

← Back to Oncology Nursing hub